The Rogosin Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1983-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.rogosin.org/
Repository Study of Autosomal Dominant Polycystic Kidney Disease
Withdrawn
- Conditions
- Autosomal Dominant Polycystic Kidney Disease
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- The Rogosin Institute
- Registration Number
- NCT01988038
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Recruiting
- Conditions
- Kidney Failure, ChronicLupus NephritisDiabetic NephropathyGlomerulonephritis, IGAKidney Diseases
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 2000
- Registration Number
- NCT01802034
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Treatment Modification to Reduce Symptom Burden in Hemodialysis
Not Applicable
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Other: Treatment modification
- First Posted Date
- 2013-01-25
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 16
- Registration Number
- NCT01775800
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Change of Fructose to Fat in South Asians
Not Applicable
Completed
- Conditions
- Cardiovascular DiseaseElevated TriglyceridesDiabetesDyslipidemia
- Interventions
- Other: Fructose + Glucose Beverage
- First Posted Date
- 2012-03-26
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 39
- Registration Number
- NCT01562782
- Locations
- 🇺🇸
Weill Cornell Medical College Clinical and Translational Science Center (CTSC), New York, New York, United States
🇺🇸The Rogosin Institute, New York, New York, United States
Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- Biological: Cancer Macrobead placement in abdominal cavity
- First Posted Date
- 2010-08-03
- Last Posted Date
- 2019-01-16
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 1
- Registration Number
- NCT01174368
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Velcade for Proliferative Lupus Nephritis
- First Posted Date
- 2010-07-26
- Last Posted Date
- 2012-04-24
- Lead Sponsor
- The Rogosin Institute
- Registration Number
- NCT01169857
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease
Completed
- Conditions
- Chronic Kidney DiseaseKidney InjuryProteinuria
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 119
- Registration Number
- NCT01156428
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Completed
- Conditions
- Polycystic Kidney, Autosomal DominantChronic Kidney Disease
- First Posted Date
- 2010-05-03
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 42
- Registration Number
- NCT01114594
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Recruiting
- Conditions
- Homozygous Familial Hypercholesterolemia
- First Posted Date
- 2010-04-23
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 60
- Registration Number
- NCT01109368
- Locations
- 🇺🇸
The Rogosin Institute, Weill Cornell Medical College, New York, New York, United States
Pilot Study of Velcade® in IgA Nephropathy
Phase 4
Completed
- Conditions
- IgA NephropathyChronic Kidney Disease
- Interventions
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2018-11-16
- Lead Sponsor
- The Rogosin Institute
- Target Recruit Count
- 11
- Registration Number
- NCT01103778
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath